EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Malignancy as a Predictor and Potential Modifier of Laboratory Biomarker Prognostic Value in Acute Pulmonary Embolism

Sonja Salinger iD, Aleksandra Kozic iD, Stefan Ilic, Boris Dzudovic iD, Bojana Subotic, Jovan Matijasevic, Marija Benic, Tamara Kovacevic Preradovic iD, Ana Kovacevic-Kuzmanovic, Irena Mitevska iD, Vladimir Miloradovic, Ema Jevtic iD und 2 weitere

Diagnostics · 07.07.2026 · 16 (13) · 2130

DOI: 10.3390/diagnostics16132130 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diagnostics, online erschienen am 07.07.2026. Verfasst von Sonja Salinger und 13 weiteren Autor:innen. Beteiligte Einrichtung: Clinic of Cardiology, Clinical Center Nis, 18000 Nis, Serbia. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Acute pulmonary embolism (PE) is a major cause of cardiovascular mortality, with prognosis influenced by hemodynamic status, comorbidities, and biomarker profiles. Although several laboratory markers have demonstrated prognostic relevance in PE, it remains unclear whether their predictive performance differs in patients with active malignancy. This study aimed to identify laboratory predictors of in-hospital mortality in acute PE and evaluate the modifying effect of malignancy on biomarker-based prognostic stratification.

Methods

This retrospective multicenter cohort study included 2803 consecutive patients with confirmed acute PE enrolled in the Regional Pulmonary Embolism Registry (REPER) between January 2015 and April 2026. Univariate and multivariable logistic regression analyses were performed to identify predictors of in-hospital mortality in the overall cohort and subgroups stratified by malignancy status. Interaction analyses were used to formally assess effect modification by malignancy.

Results

Active malignancy was present in 14.02% of patients, and overall in-hospital mortality was 11.10%. Multivariable analysis identified malignancy, CRP, glucose, creatinine clearance (CrCl), platelet count, and ESC risk category as independent predictors of in-hospital mortality. In-hospital mortality was significantly higher in patients with malignancy compared with those without (16.54% vs. 10.21%, p < 0.001). In the malignant subgroup, CRP and glucose remained independent predictors, whereas in non-malignant patients, CRP, glucose, CrCl, and ESC risk category were independently associated with outcome. Significant interactions between malignancy status and CrCl, age, glucose, and total leukocyte count suggest that the prognostic contribution of these variables may differ according to cancer status.

Conclusions

Active malignancy is an independent predictor of in-hospital mortality in acute PE and appears to be associated with a more severe presentation. Our findings suggest that malignancy may also modify the prognostic performance of certain biomarkers. These observations suggest that conventional risk stratification tools may require cautious, malignancy-aware interpretation and that prospective studies validating malignancy-adapted prognostic frameworks are warranted.

Schlagwörter

Stichwörter der Autor:innen

biomarkersmalignancypulmonary embolismrisk stratification

Autor:innen und Institutionen

  • Clinic of Cardiology, Clinical Center Nis, 18000 Nis, Serbia.
  • Faculty of Medicine, University of Nis, 18000 Nis, Serbia.
  • Medical Faculty of the Military Medical Academy, University of Defense, 11000 Belgrade, Serbia.
  • Clinic of Emergency Internal Medicine, Military Medical Academy, 11000 Belgrade, Serbia.
  • Clinic of Cardiology, Military Medical Academy of Belgrade, 11000 Belgrade, Serbia.
  • Institute of Pulmonary Diseases Vojvodina, 21000 Novi Sad, Serbia.

ORCID-Profile: Sonja Salinger, Aleksandra Kozic, Boris Dzudovic, Tamara Kovacevic Preradovic, Irena Mitevska, Ema Jevtic, Slobodan Obradovic

Zitieren

APA

Salinger, S., Kozic, A., Ilic, S., Dzudovic, B., Subotic, B., Matijasevic, J., Benic, M., Kovacevic Preradovic, T., Kovacevic-Kuzmanovic, A., Mitevska, I., Miloradovic, V., Jevtic, E., Neskovic, A., & Obradovic, S. (2026). Malignancy as a Predictor and Potential Modifier of Laboratory Biomarker Prognostic Value in Acute Pulmonary Embolism. Diagnostics, 16(13), 2130. https://doi.org/10.3390/diagnostics16132130

Vancouver

Salinger S, Kozic A, Ilic S, Dzudovic B, Subotic B, Matijasevic J, et al. Malignancy as a Predictor and Potential Modifier of Laboratory Biomarker Prognostic Value in Acute Pulmonary Embolism. Diagnostics. 2026;16(13):2130. doi:10.3390/diagnostics16132130

BibTeX
@article{Salinger2026,
  author = {Salinger, Sonja and Kozic, Aleksandra and Ilic, Stefan and Dzudovic, Boris and Subotic, Bojana and Matijasevic, Jovan and Benic, Marija and Kovacevic Preradovic, Tamara and Kovacevic-Kuzmanovic, Ana and Mitevska, Irena and Miloradovic, Vladimir and Jevtic, Ema and Neskovic, Aleksandar and Obradovic, Slobodan},
  title = {Malignancy as a Predictor and Potential Modifier of Laboratory Biomarker Prognostic Value in Acute Pulmonary Embolism},
  journal = {Diagnostics},
  year = {2026},
  volume = {16},
  number = {13},
  pages = {2130},
  doi = {10.3390/diagnostics16132130}
}
Kostenlos starten →